Evidence map›Paper›PMID 31485280›Full record

ArticleDisease markers2019

Associations between

Xingming Huang, Can Shen, Yan Zhang, Qin Li, Kai Li, Yanyun Wang, Yaping Song, Min Su, Bin Zhou, Wei Wang

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Disease markers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.7field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Association ofTurkish journal of obstetrics and gynecology · 2025
    Article
  2. Associations ofCancers · 2024
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Xingming HuangDepartment of Pathology, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
Can ShenLaboratory of Molecular Translational Medicine, Center for Translational Medicine, Key Laboratory of Birth Defects & Related Diseases of Women & Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
Yan ZhangDepartment of Pathology, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
Qin LiLaboratory of Molecular Translational Medicine, Center for Translational Medicine, Key Laboratory of Birth Defects & Related Diseases of Women & Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China.ORCID https://orcid.org/0000-0001-5455-6109
Kai LiLaboratory of Molecular Translational Medicine, Center for Translational Medicine, Key Laboratory of Birth Defects & Related Diseases of Women & Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
Yanyun WangLaboratory of Molecular Translational Medicine, Center for Translational Medicine, Key Laboratory of Birth Defects & Related Diseases of Women & Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China.ORCID https://orcid.org/0000-0002-8102-8851
Yaping SongLaboratory of Molecular Translational Medicine, Center for Translational Medicine, Key Laboratory of Birth Defects & Related Diseases of Women & Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
Min SuLaboratory of Molecular Translational Medicine, Center for Translational Medicine, Key Laboratory of Birth Defects & Related Diseases of Women & Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
Bin ZhouLaboratory of Molecular Translational Medicine, Center for Translational Medicine, Key Laboratory of Birth Defects & Related Diseases of Women & Children (Sichuan University), Ministry of Education, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China.ORCID https://orcid.org/0000-0003-3484-3340
Wei WangDepartment of Pathology, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China.ORCID https://orcid.org/0000-0001-8700-364X
Sichuan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEpithelial ovarian cancer (EOC) is highly lethal worldwide. Factors involved in the inflammation and hormone-associated signaling pathway play vital roles in EOC carcinogenesis. The transforming growth factor-

methodsThree single nucleotide polymorphisms (SNPs) (rs237028, rs521845, and rs652921) of

resultsThe rs237028 polymorphism was significantly associated with an increased risk of EOC with an allelic genetic model (A

conclusionsOur study indicated that the rs237028 polymorphism in the

Indexed as

Polymorphism, Single NucleotideAdaptor Proteins, Signal TransducingAdultAgedCarcinoma, Ovarian EpithelialChinaFemaleHumansMiddle AgedOvarian NeoplasmsAdaptor Proteins, Signal TransducingTAB2 protein, human

Identifiers

PMID31485280
PMCPMC6710735
OpenAlexW2968672465

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.